|
Market Closed -
Nasdaq
01:30:00 22/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 6.290 USD | +0.64% |
|
-23.39% | -55.67% |
| 12/08 | RTW Biotech's Avere to go public in US in reverse merger with NextCure | AN |
| 12/08 | RTW Biotech to Inject $6 Million in Avere Therapeutics Ahead of Reverse Merger | MT |
Chart: Technical Analysis
Stock exchange
Nasdaq
NXTC 6.290 $
+0.64%
2L
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| NXTC | 6.290USD | +0.64% | 2L $ | |
CBOE
| NXTC | 6.300USD | +0.64% | 5.44T $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 8.28 | 13.6 | 14.09 |
| Spread/Res. | -24.03% | -53.75% | -55.36% |
| Spread/Supp. | +8.82% | +293.12% | +282.37% |
| Support | 5.78 | 1.6 | 1.645 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NXTC Stock
- Charts NextCure, Inc.
Select your edition
All financial news and data tailored to specific country editions
